logo
From French Tips To Butter Yellow, The Best BIAB Pedicures To See You Through A Heatwave

From French Tips To Butter Yellow, The Best BIAB Pedicures To See You Through A Heatwave

Elle09-07-2025
Builder In A Bottle, also known as BIAB, is an increasingly popular manicure option for those who are looking to strengthen and grow their natural nails.
But BIAB isn't exclusively designed for the hands. BIAB pedicures are proving to be useful for anyone whose nails require extra care, strength and protection. In the warmer months, when our toes are even more exposed to the elements – think sand, sea, and being out and about in summer sandals – BIAB pedicures promise longevity and high-performance wear.
'While we recommend applying it in a thin layer (more like a rubber base), BIAB™ still delivers its key benefit: flexible strength,' says Giorgia Cappella, head of education and spa at The GelBottle Inc.
Essentially, BIAB works by 'flexing' with the natural nail. 'This helps to prevent breakages and protect the nail from damage - ideal for weaker or damaged toenails that need a little extra support,' adds Cappella.
According to Cappella, those with active lifestyles or athletes prone to toe trauma will benefit from the strengthening effects of a BIAB pedicure. Plus, if you are loyal to a BIAB manicure, you can get matching shades for your toes. 'Clients are often drawn to the beautiful, wearable shades and the added durability, which makes it perfect for holidays or long-lasting pedis,' Cappella tells ELLE.
Similar to BIAB manicures, they can last up to 4 weeks depending on the individual's lifestyle. But do make sure to monitor your toenail's growth. 'If toenails get too long, they can press into shoes and cause damage to the nail matrix,' cautions Cappella. While BIAB is durable, it's always important to regularly check on your nails and maintain it regularly to ensure nail health.
When used correctly, there are no major downsides to BIAB, as long as the product isn't over-applied or built too thick, as toenails are generally stronger than the nails on your hands.
As with manicures, sunny designs and pastel tones are set to take over our toes. Cappella is a big fan of soft baby blues, lilacs, yellows and minty greens from The Gel Bottle's Pastel BIAB collection. 'These dreamy shades pair perfectly with sandals and sunshine, and are a gorgeous way to add colour without overpowering your look.'
A powdery pink base makes for a subtle take on the French pedicure.
Take a cue from TikTok's 'princess nails' trend and try an extremely pretty, sheer pink pedicure with an immaculate finish.
Pale lemon is still very much on the radar for summer, delivering a hint of sunshine without overpowering the rest of your look.
ELLE Collective is a new community of fashion, beauty and culture lovers. For access to exclusive content, events, inspiring advice from our Editors and industry experts, as well the opportunity to meet designers, thought-leaders and stylists, become a member today HERE.
Medina Azaldin is the beauty editor of ELLE and Harper's Bazaar UK, working across print and digital features. She has more than seven years journalism experience and has previously written for Red and Good Hoousekeeping. When she's not demystifying the latest skincare ingredient, sniffing out the next big perfume trend or uncovering the science behind wellness practices, you'll most likely find her in Hatchards Piccadilly or watching a crime series with her cats. Oh, and she's a competitive cheerleader, too.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

MusiCares ® Partners with Maven Clinic to Offer Inclusive Family Planning and Reproductive Health Support to Music Professionals
MusiCares ® Partners with Maven Clinic to Offer Inclusive Family Planning and Reproductive Health Support to Music Professionals

Business Wire

timean hour ago

  • Business Wire

MusiCares ® Partners with Maven Clinic to Offer Inclusive Family Planning and Reproductive Health Support to Music Professionals

SANTA MONICA, Calif.--(BUSINESS WIRE)--MusiCares ®, the leading music charity supporting the health and wellness of music professionals, has partnered with Maven Clinic, the world's largest virtual clinic for women's and family health. This collaboration expands MusiCares' commitment to holistic support by providing eligible music professionals with free access to Maven's inclusive virtual care and support. The platform offers personalized care across every stage of life, including family planning, fertility, maternity, parenting, mental health, and menopause. MusiCares clients can now access 24/7 support through Maven's virtual platform, connecting with hundreds of providers across 30 specialties—including OB-GYNs, doulas, pediatricians, career coaches, mental health professionals, nutritionists, and more. Care is available in 35 languages, including Spanish, French, German, and Hindi, making it easier for members to find timely, culturally inclusive support that fits their needs. Appointments are typically available within an hour, and members are paired with a dedicated Care Advocate who guides them throughout their journey and connects them to in-person resources when needed. Beyond one-on-one care, members can also engage with expert-backed educational content and peer communities tailored to their stage of life and needs. All virtual care within the Maven app is free to eligible MusiCares clients and available with no limit to the number of sessions. In-app copays and associated costs are fully covered by MusiCares. If a client is referred to an external provider through Maven, discounted rates may be available depending on the region. 'Maven and MusiCares both exist as safety nets for people at crucial points in their lives,' said Theresa Wolters, Interim Executive Director and Vice President of Health & Human Services at MusiCares. 'Just as we consider the many overlapping challenges a music professional may face, whether that's financial hardship, mental health struggles, recovery, or caregiving responsibilities, Maven understands that reproductive health and family building are deeply interconnected with all aspects of a person's life. This partnership offers care that sees the whole person.' This partnership reflects MusiCares' commitment to supporting music professionals beyond immediate needs, ensuring they have ongoing access to resources that help them stay healthy, resilient, and able to focus on their careers. 'Too often, family planning resources focus on a single milestone, but real life is far more complex,' added Wolters. 'Our clients are touring parents, caregiving partners, new moms navigating postpartum depression, and seasoned professionals managing perimenopause while working. With Maven, we can now offer continuous, compassionate care that supports them through each chapter of their lives.' 'Reproductive and family health doesn't exist in isolation—it's deeply connected to how we live, work, and care for others,' said Isha Vij, Maven's senior vice president of employer growth. 'Together with MusiCares, we're helping people access care that supports not just their health, but their ability to keep creating, performing and showing up in the world.' Eligible MusiCares clients, including those with at least five years of industry experience or six commercially released recordings or videos, can now access Maven's network of OB-GYNs, mental health providers, lactation consultants, fertility experts, pediatricians, and more through the app. To apply for Maven services through MusiCares, please visit To learn more about MusiCares' health and human services or to apply for support, visit ABOUT MUSICARES MusiCares helps the humans behind music because music gives so much to the world. Offering preventive, emergency and recovery programs, MusiCares is a safety net supporting the health and welfare of the music community. Founded by the Recording Academy in 1989 as a U.S.-based 501(c)(3) charity, MusiCares safeguards the well-being of all music people through direct financial grant programs, networks of support resources, and tailored crisis relief efforts. For more information please visit: ABOUT MAVEN Maven is the world's largest virtual clinic for women and families on a mission to make healthcare work for all of us. Maven's award-winning digital programs provide clinical, emotional, and financial support all in one platform, spanning fertility & family building, maternity & newborn care, parenting & pediatrics, and menopause & midlife. More than 2,000 employers and health plans trust Maven's end-to-end platform to improve clinical outcomes, reduce healthcare costs, and provide equity in benefits programs. Recognized for innovation and industry leadership, Maven has been named to the Time 100 Most Influential Companies, CNBC Disruptor 50, Fast Company Most Innovative Companies, and FORTUNE Best Places to Work. Founded in 2014 by CEO Kate Ryder, Maven has raised more than $425 million in funding from top healthcare and technology investors including General Catalyst, Sequoia, Dragoneer Investment Group, Oak HC/FT, StepStone Group, Icon Ventures, and Lux Capital. To learn more about Maven, visit us at

Seek Labs Unveils Investigational, Equipment-Free Molecular Prototype for MTB on Rapid-Deploy SeekIt™ Platform
Seek Labs Unveils Investigational, Equipment-Free Molecular Prototype for MTB on Rapid-Deploy SeekIt™ Platform

Business Wire

time2 hours ago

  • Business Wire

Seek Labs Unveils Investigational, Equipment-Free Molecular Prototype for MTB on Rapid-Deploy SeekIt™ Platform

SALT LAKE CITY--(BUSINESS WIRE)--Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, today announced a significant advancement in the global fight against tuberculosis (TB) with an investigational prototype for Mycobacterium tuberculosis (MTB) detection on its SeekIt™ platform. In internal analytical testing, the MTB SeekIt test delivered accurate results in under 60 minutes. Importantly, this innovation addresses a key limitation that has historically hindered effective TB diagnostics: breaking apart MTB's waxy, lipid-rich cell wall to gain access to detectable genetic material. In internal testing, SeekIt's proprietary chemical lysis step achieved this in just 15 minutes without heat, mechanical disruption, or complex lab tools and skilled operators. Seek Labs achieved a functional investigational prototype in one quarter by leveraging its suite of in-house, pre-validated diagnostic technologies, focusing new innovation efforts on the MTB-specific lysis step. Share Seek Lab's MTB test demonstrates the speed, adaptability, and field-readiness of the modular SeekIt platform. All SeekIt's components—lysis chemistry, extraction, amplification, and detection—are proprietary to Seek Labs, exclusively discovered and developed in-house, and have been internally validated for performance and integration across multiple applications. The Global TB Testing Gap TB kills more than 1.25 million people each year, with nearly one in three cases going undiagnosed. In high-burden, resource-limited settings, centralized molecular tests face major hurdles: Pathogen complexity: MTB's waxy, lipid-rich cell wall has proven intractable to portable lysis methods for decades. Infrastructure dependence: Gold-standard molecular tests require expensive, power-intensive instruments, refrigeration, and highly skilled (or trained) operators. Sample limitations: Sputum collection is challenging for many patients and can deter testing. 'TB diagnostics have long been limited by gaps in both infrastructure and innovation that have often meant severe consequences for patient care and public health,' said Jared Bauer, CEO of Seek Labs. 'Our rapid, point-of-care SeekIt MTB test is designed to enable molecular-level detection in settings where access to equipment and electricity may be limited.' From Sample to Result: A Simplified Workflow At the core of the MTB SeekIt test is a proprietary, single-step chemical lysis buffer, involving a specially-formulated solution that disrupts MTB cells to release their genomic DNA. This breakthrough innovation takes just 15 minutes at room temperature, while competing methods (high-heat incubation or mechanical bead-beating) require longer times plus expensive equipment, specialized technicians, and complex infrastructure. More importantly, the integrated SeekIt test means the lysate itself flows seamlessly into SeekIt's downstream test components: Seek Extraction™ — A proprietary membrane-based binding system, developed and validated by Seek Labs, that rapidly captures MTB DNA without lab instruments. In validation testing, the MTB DNA yield for Seek Extraction was consistently more than 70% when compared to leading spin-column kits. Seek Amplification™ — A proprietary process that exponentially copies DNA at a constant temperature, detecting as few as 10 MTB genomic copies in 30 minutes without thermal cycling (internally validated), the conventional lab-based method. Molecular Lateral Flow Assay (mLFA) — A test strip that delivers clear, visual results in minutes indicating the presence of amplified DNA in a manner that can be optionally paired with the SeekIt mobile app for digital analysis and connectivity. Speed as a Strategy Conventional development of a molecular test for MTB can take a year or more. Seek Labs achieved a functional investigational prototype in one quarter by leveraging its suite of in-house, pre-validated diagnostic technologies, focusing new innovation efforts on the MTB-specific lysis step. This rapid-deployment approach illustrates how SeekIt can be rapidly developed for numerous high-priority diseases in record time. 'This was more than a fast project; it's proof of our platform's flexibility,' said Kim Wirthlin, Chief Strategy Officer. 'By focusing our innovation on the MTB-specific lysis step for compatibility with our downstream isothermal amplification, we solved one of TB diagnostics' toughest technical challenges and produced a functional investigational prototype in a single quarter.' From Conference to Collaboration Seek Labs will debut the MTB SeekIt prototype at the 2025 Next Generation Dx Conference (August 18–20, 2025, Washington, D.C.), including: Podium Presentation — Enabling Point of Care Diagnostics Track, Tuesday, August 19 at 10:00 AM ET. Scientific Poster — Detailing the proprietary lysis chemistry, rapid development process, and validation data. Seek Labs is actively seeking partners across global health (ministries of health, TB-focused NGOs, and diagnostics distributors in high-burden regions such as sub-Saharan Africa and Southeast Asia) to advance the MTB SeekIt test through clinical validation, regulatory approval, and deployment. 'Innovation means nothing if it doesn't reach people,' said Bauer. 'We want to work with those who share our vision to advance development of accurate, accessible TB testing solutions wherever they're needed most.' About Seek Labs At Seek Labs, we don't wait for change—we build it. We're pursuing the breakthroughs the world can't wait for by developing programmable 'seek-and-destroy' therapeutics and point-of-care molecular diagnostics that close the gap between outbreak and intervention. At the core of this mission is a layered architecture: BioSeeker™ serves as the Intelligence Layer, continuously mapping conserved viral vulnerabilities in real time; these insights activate our Deployment Layers (PTAP™ for programmable therapeutics and SeekIt™ for molecular diagnostics), forming a full-stack development engine designed to accelerate response, innovation, and impact across global health. Headquartered in Salt Lake City, Seek Labs is a proud member of BioHive, Utah's collaborative life sciences ecosystem. Together with our partners, we're building faster, smarter solutions for the world's most urgent health challenges. Forward-Looking Statements and Regulatory Disclaimer This press release contains forward-looking statements, including statements regarding development timelines, clinical validation, regulatory pathways, and potential collaborations. Forward-looking statements are based on current expectations and assumptions and are subject to risks and uncertainties—including scientific, regulatory, manufacturing, clinical, and commercial risks—that could cause actual results to differ materially. The MTB SeekIt assay is an investigational device. Limited by Federal law to investigational use.

Firstsource and Guidehealth Partner to Accelerate AI-Enabled Value-Based Care Innovation for Health Plans
Firstsource and Guidehealth Partner to Accelerate AI-Enabled Value-Based Care Innovation for Health Plans

Business Wire

time4 hours ago

  • Business Wire

Firstsource and Guidehealth Partner to Accelerate AI-Enabled Value-Based Care Innovation for Health Plans

MUMBAI, India & DALLAS--(BUSINESS WIRE)-- Firstsource Solutions Limited (NSE:FSL, BSE:532809), a leading global provider of business management services and an RP-Sanjiv Goenka Group company, today announced a strategic partnership with Guidehealth – a pioneer in quality outcomes and value-based care innovation. This collaboration will empower health plans to deliver measurable value for members and providers by accelerating the adoption of next-generation, outcome-driven care models and preventive care. Firstsource's AI-first approach – recognized as a 'Front-Runner' in Generative AI for Healthcare Payers by Everest Group – combines deep domain expertise with its proprietary relAI™ suite and UnBPOᵀᴹ transformation model to help health plans move beyond incremental change. By embedding AI into operations, Firstsource enables streamlined processes, enhanced member engagement, and better health outcomes through intelligent, interoperable platforms that drive agility and measurable results. Guidehealth brings a proven track record in value-based care innovation, helping payers and providers shift to models that reward quality, efficiency, and improved patient outcomes. By combining advanced analytics, clinical expertise, and AI-integrated workflows, Guidehealth supports the implementation and optimization of Medicare Advantage Stars and value-based arrangements – delivering >4 Star performance and measurable improvements in care coordination, cost control, and member satisfaction within the first year. Venkatgiri Vandali, Head, Healthcare & Lifesciences, Firstsource, shared, 'This partnership marks a pivotal step in our mission to redefine healthcare operations. We're proud to support Guidehealth's bold vision for value-based care – uniting their innovation with Firstsource's AI-first, UnBPOᵀᴹ model. By integrating intelligent automation, deep domain expertise, and a human-first mindset, we're enabling health plans to deliver smarter, more personalized, and outcomes-driven care at scale. Together, we're orchestrating a new era of healthcare transformation.' Sanjay Doddamani, MD & CEO, Guidehealth, said, 'Guidehealth is committed to making great healthcare affordable for all by advancing value-based care by combining AI and empathy and delivering tech-enabled healthcare services across the healthcare system. Partnering with Firstsource enables us to combine our expertise in care delivery with cutting-edge AI and digital platforms, creating a powerful ecosystem for health plans and providers. We are excited to deliver measurable value for our clients and their network of doctors and patients.' Firstsource and Guidehealth will offer health plans a comprehensive suite of solutions that: Accelerate successful value-based care adoption through AI, advanced analytics, and clinical expertise Streamline claims and care management using automation and data-driven insights to ensure timely, appropriate care and operational efficiency Enhance member engagement and performance by delivering personalized, tech-enabled experiences that drive measurable improvements in MA Stars, cost, and clinical outcomes across the healthcare value chain Together, Firstsource and Guidehealth offer a powerful, tech-enabled partnership that blends operational excellence with clinical insight. Their combined capabilities help clients transform healthcare delivery at scale – accelerating digital maturity, improving health outcomes, and driving performance in a value-based care environment. About Firstsource Firstsource Solutions Limited, an RP-Sanjiv Goenka Group company (NSE: FSL, BSE: 532809, Reuters: Bloomberg: FSOL:IN), is a global leader providing transformational solutions and services spanning the customer lifecycle across Healthcare, Banking and Financial Services, Communications, Media and Technology, Retail, and other diverse industries. With a global footprint across US, UK, India, Philippines, Mexico, Romania, Turkey, Trinidad & Tobago, South Africa, and Australia, we 'make it happen' for our clients, solving their biggest challenges with hyper-focused, domain-centered teams and cutting-edge tech, data, and analytics. Our inch-wide, mile-deep practitioners work collaboratively, leveraging UnBPO™ - our differentiated approach to reimagining traditional outsourcing - to deliver real-world, future-focused solutions that drive speed, scale, and smarter decision, turning transformation into tangible results for our clients. ( About Guidehealth Guidehealth is dedicated to making great healthcare affordable for all. The company partners with health systems and clinical networks to bring scale and predictable performance to value-based care across all lines of business. Led by physicians, Guidehealth augments existing primary care capacity using innovative AI-based protocols, remotely embedded Healthguides™, and a meticulously designed framework to predict those patients most in need of support in and beyond the exam room. For more information, visit

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store